PRESS
“Until I read [this book], about the outrageous behavior of an obscure drug company, I hadn’t appreciated the full extent of the filth or the dark stain the opioid sector has left on the entire industry… A fast-paced and maddening account… What’s most surprising and powerful about [it] is not one company’s criminality — we’ve grown inured to corporations behaving badly — as much as how institutionalized these practices were across the modern drug industry… Hughes recounts the chase and trial in dramatic fashion.”
THE NEW YORK TIMES BOOK REVIEW
“A story of ‘power, greed, and betrayal.’ Author Evan Hughes joins Morning Joe to discuss his new book.”
MORNING JOE — MSNBC
“A tightly focused and insightful account of how a company that went public in the most successful IPO of 2013 soon ended up a poster child for corporate greed… Marbled throughout… are vivid portraits of key executives… As a gripping tale of one drug firm’s unscrupulous efforts to profit from pain, [this book] is hard to beat.”
THE BOSTON GLOBE
“A revelatory deep dive into the ignominious history of the pharmaceutical manufacturer Insys Therapeutics… Hughes does an excellent job of illuminating the inner workings of Big Pharma’s malicious practices… A powerful indictment.”
Publishers Weekly (starred review)
“A seamless, fly-on-the-wall account that can be devoured in one sitting.”
THE GLOBE & MAIL (CANADA)
“A bombshell courtroom drama worthy of prime-time television. Hughes’ compact retelling of the Insys saga unfolds like a blockbuster film. Fans of Bad Blood by John Carreyrou will be captivated by this story of unbelievable greed and hubris. A must-read.”
Booklist (starred review)
“As compelling as a true crime documentary… Even readers with little background on the topic will find themselves riveted by the narrative… Hughes perfectly captures the human impact of pharmaceutical sales and corporate greed… A book readers will not soon forget.”
“A journalist pulls back the curtain on the scandals that sent the first pharmaceutical executives to prison for their role in the opioid crisis… A brisk and engaging account.”